U.S., Nov. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07255209) titled 'A Study of IBI362 in Chinese Adolescents With Obesity or Overweight' on Nov. 19.
Brief Summary: The study is designed to assess the efficacy and safety of multiple doses of IBI362 in Chinese adolescent subjects with obesity or overweight. It plans to enroll 180 adolescents (aged >=12 and <18 years) who have failed to achieve a 5 kg weight reduction after at least 12 weeks of dietary and exercise intervention.
Study Start Date: Dec. 01
Study Type: INTERVENTIONAL
Condition:
Adolescents With Obesity or Overweight With Weight-Related Comorbidities
Intervention:
DRUG: Placebo
Placebo SA.QW
DRUG: IBI362
IBI362 SA.QW
Recruitment ...